Hideki Nishimura

Summary

Affiliation: Kobe University
Country: Japan

Publications

  1. ncbi request reprint Radiographic pulmonary and pleural changes after carbon ion irradiation
    Hideki Nishimura
    Research Center of Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan
    Int J Radiat Oncol Biol Phys 55:861-6. 2003
  2. pmc Radiotherapy for stage I or II hypopharyngeal carcinoma
    Hideki Nishimura
    Division of Radiation Oncology, Department of Radiology, Kobe University Graduate School of Medicine, 7 5 2 Kusunoki cho, Chuo Ku, Kobe, Hyogo 650 0017, Japan
    J Radiat Res 53:892-9. 2012
  3. ncbi request reprint Proton-beam therapy for olfactory neuroblastoma
    Hideki Nishimura
    Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Int J Radiat Oncol Biol Phys 68:758-62. 2007
  4. ncbi request reprint Carbon ion radiotherapy for stage I non-small cell lung cancer
    Tadaaki Miyamoto
    Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, 9 1 Anagawa, 4 chome, Inage Ku, Chiba shi 263 8555, Japan
    Radiother Oncol 66:127-40. 2003
  5. ncbi request reprint Dosimetric factors used for thoracic X-ray radiotherapy are not predictive of the occurrence of radiation pneumonitis after carbon-ion radiotherapy
    Masashi Koto
    Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan
    Tohoku J Exp Med 213:149-56. 2007
  6. ncbi request reprint Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy
    Masashi Koto
    Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, 4 9 1 Anagawa, Inage Ku, Chiba shi, Chiba 263 8555, Japan
    Radiother Oncol 71:147-56. 2004
  7. ncbi request reprint Preoperative carbon ion radiotherapy for non-small cell lung cancer with chest wall invasion--pathological findings concerning tumor response and radiation induced lung injury in the resected organs
    Naoyoshi Yamamoto
    Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, 9 1 Anagawa, 4 chome, Inage Ku, Chiba shi, Chiba 263 8555, Japan
    Lung Cancer 42:87-95. 2003
  8. pmc Radiotherapy for Japanese elderly patients with cervical cancer: preliminary survival outcomes and evaluation of treatment-related toxicity
    Kenji Yoshida
    Department of Radiation Oncology, Kobe University Graduate School of Medicine, 7 5 2 Kusunokicho, Chuouku, Kobe City, Hyogo 650 0017, Japan
    Arch Gynecol Obstet 284:1007-14. 2011
  9. ncbi request reprint Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan
    Keiji Nihei
    Radiation Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba 277 8577, Japan
    Jpn J Clin Oncol 35:745-52. 2005
  10. doi request reprint Brain injury after proton therapy or carbon ion therapy for head-and-neck cancer and skull base tumors
    Daisuke Miyawaki
    Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Hyogo, Japan
    Int J Radiat Oncol Biol Phys 75:378-84. 2009

Collaborators

Detail Information

Publications19

  1. ncbi request reprint Radiographic pulmonary and pleural changes after carbon ion irradiation
    Hideki Nishimura
    Research Center of Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan
    Int J Radiat Oncol Biol Phys 55:861-6. 2003
    ..In the present study, we focus on posttreatment radiographic lung damage: specifically, its timing, features, and relation to dose-volume factors...
  2. pmc Radiotherapy for stage I or II hypopharyngeal carcinoma
    Hideki Nishimura
    Division of Radiation Oncology, Department of Radiology, Kobe University Graduate School of Medicine, 7 5 2 Kusunoki cho, Chuo Ku, Kobe, Hyogo 650 0017, Japan
    J Radiat Res 53:892-9. 2012
    ..Early detection and accurate management of local recurrence and second malignancy was deemed to be critical...
  3. ncbi request reprint Proton-beam therapy for olfactory neuroblastoma
    Hideki Nishimura
    Department of Radiation Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Int J Radiat Oncol Biol Phys 68:758-62. 2007
    ..Proton-beam therapy can provide better dose distribution compared with X-ray irradiation because of its physical characteristics, and is deemed to be a feasible treatment modality...
  4. ncbi request reprint Carbon ion radiotherapy for stage I non-small cell lung cancer
    Tadaaki Miyamoto
    Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, 9 1 Anagawa, 4 chome, Inage Ku, Chiba shi 263 8555, Japan
    Radiother Oncol 66:127-40. 2003
    ..Using carbon beams, a dose escalation study was conducted for the treatment of stage I non-small cell lung cancer (NSCLC) to determine the optimal dose...
  5. ncbi request reprint Dosimetric factors used for thoracic X-ray radiotherapy are not predictive of the occurrence of radiation pneumonitis after carbon-ion radiotherapy
    Masashi Koto
    Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, Chiba, Japan
    Tohoku J Exp Med 213:149-56. 2007
    ..The dosimetric factors used for XRT are not applicable for CRT in patients with NSCLC. The dosimetric factors for CRT remain to be developed...
  6. ncbi request reprint Local control and recurrence of stage I non-small cell lung cancer after carbon ion radiotherapy
    Masashi Koto
    Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, 4 9 1 Anagawa, Inage Ku, Chiba shi, Chiba 263 8555, Japan
    Radiother Oncol 71:147-56. 2004
    ....
  7. ncbi request reprint Preoperative carbon ion radiotherapy for non-small cell lung cancer with chest wall invasion--pathological findings concerning tumor response and radiation induced lung injury in the resected organs
    Naoyoshi Yamamoto
    Research Center Hospital for Charged Particle Therapy, National Institute of Radiological Sciences, 9 1 Anagawa, 4 chome, Inage Ku, Chiba shi, Chiba 263 8555, Japan
    Lung Cancer 42:87-95. 2003
    ..The pathological findings have thus provided evidence of the safety and effectiveness of carbon beam therapy in the treatment of NSCLC...
  8. pmc Radiotherapy for Japanese elderly patients with cervical cancer: preliminary survival outcomes and evaluation of treatment-related toxicity
    Kenji Yoshida
    Department of Radiation Oncology, Kobe University Graduate School of Medicine, 7 5 2 Kusunokicho, Chuouku, Kobe City, Hyogo 650 0017, Japan
    Arch Gynecol Obstet 284:1007-14. 2011
    ..To examine the preliminary survival outcomes and treatment-related toxicity for elderly patients with cervical cancer treated with radiotherapy (RT)...
  9. ncbi request reprint Phase II feasibility study of high-dose radiotherapy for prostate cancer using proton boost therapy: first clinical trial of proton beam therapy for prostate cancer in Japan
    Keiji Nihei
    Radiation Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba 277 8577, Japan
    Jpn J Clin Oncol 35:745-52. 2005
    ..To assess the feasibility of high-dose radiotherapy for prostate cancer using proton boost therapy following photon radiotherapy...
  10. doi request reprint Brain injury after proton therapy or carbon ion therapy for head-and-neck cancer and skull base tumors
    Daisuke Miyawaki
    Department of Radiology, Hyogo Ion Beam Medical Center, Tatsuno, Hyogo, Japan
    Int J Radiat Oncol Biol Phys 75:378-84. 2009
    ..To assess the incidence of early delayed or late morbidity of the brain after particle therapy for skull base tumors and head-and-neck cancers...
  11. doi request reprint Nuclear factor-kappaB expression as a novel marker of radioresistance in early-stage laryngeal cancer
    Kenji Yoshida
    Division of Radiation Oncology, Kobe University Graduate School of Medicine, Hyogo, Japan
    Head Neck 32:646-55. 2010
    ..The aim of this study was to evaluate the significance of nuclear factor-kappa B (NF-kappaB) expression as a marker of radioresistance in early-stage laryngeal cancer...
  12. ncbi request reprint High-dose proton beam therapy for Stage I non-small-cell lung cancer
    Keiji Nihei
    Radiation Oncology Division, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
    Int J Radiat Oncol Biol Phys 65:107-11. 2006
    ..To evaluate retrospectively the safety and efficacy of high-dose proton beam therapy (PBT) for Stage I non-small-cell lung cancer (NSCLC)...
  13. ncbi request reprint Vitamin K2-derived compounds induce growth inhibition in radioresistant cancer cells
    Helfi Amalia
    Divisions of Radiation Oncology, Kobe University Graduate School of Medicine, 7 5 2 Kusunokicho Chuouku Kobe City, Hyogo 650 0017, Japan
    Kobe J Med Sci 56:E38-49. 2010
    ..The efficacy of those compounds was related to the generation of ROS. These findings together might pave the way for the treatment of radioresistant or recurrent cancers...
  14. doi request reprint Effect of heterogeneity correction on dosimetric parameters of radiotherapy planning for thoracic esophageal cancer
    Masao Nakayama
    Division of Radiation Oncology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan Electronic address
    Med Dosim 39:31-3. 2014
    ..4%, and 0.5%, respectively. These results suggest that HC might have a more pronounced effect on the percentages of lung volume receiving lower doses (e.g., V5 and V10) than on the dosimetric parameters related to the PTV and other OARs. ..
  15. ncbi request reprint [Heavy-ion therapy for non-small cell lung cancer]
    Tadaaki Miyamoto
    Research Center of Charged Particles, National Institute of Radiological Sciences, Chiba, Japan
    Nihon Geka Gakkai Zasshi 103:250-5. 2002
    ..For locally advanced lung cancer treated with carbon beam therapy, excellent local control comparable to that in stage INSCLC has been demonstrated and offers hopeful prospects for the treatment of lung cancer...
  16. doi request reprint Long-term outcome and patterns of failure in primary ocular adnexal mucosa-associated lymphoid tissue lymphoma treated with radiotherapy
    Naoki Hashimoto
    Division of Radiation Oncology, Kobe University Graduate School of Medicine, Hyogo, Japan
    Int J Radiat Oncol Biol Phys 82:1509-14. 2012
    ..To evaluate the long-term treatment outcome and disease behavior of primary ocular adnexal MALT (mucosa-associated lymphoid tissue) lymphoma (POAML) after treatment with radiotherapy...
  17. pmc Patterns of failure after multimodal treatments for high-grade glioma: effectiveness of MIB-1 labeling index
    Kazuyuki Uehara
    Division of Radiation Oncology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan
    Radiat Oncol 7:104. 2012
    ....
  18. ncbi request reprint Cell biological basis for combination radiotherapy using heavy-ion beams and high-energy X-rays
    Yusuke Demizu
    Division of Radiology, Kobe University Graduate School of Medicine, 7 5 2 Kusunoki cho, Chuo Ku, Kobe, Hyogo 650 0017, Japan
    Radiother Oncol 71:207-11. 2004
    ..This fact provides important information about the combined therapy of carbon-beam and X-ray...
  19. ncbi request reprint Long-term outcome after multidisciplinary approach for leptomeningeal carcinomatosis in a non-small cell lung cancer patient with poor performance status
    Tatsuya Nagano
    Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan
    Intern Med 50:3019-22. 2011
    ..6 months after the initiation of erlotinib therapy. This multidisciplinary approach may be particularly useful in terms of increasing survival and improving quality of life...